Nsclc Advanced Non Small Cell Lung Cancer Clinical Trials

ReadTheTrial indexes 2 studies for Nsclc Advanced Non Small Cell Lung Cancer. The most common development stage is N/A (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Nsclc Advanced Non Small Cell Lung Cancer.

Pipeline by Phase

PhaseTrialsDistribution
N/A 1
50%
Phase 2 1
50%

Trial Status Breakdown

Trials for Nsclc Advanced Non Small Cell Lung Cancer

Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis

NCT07348965 · RECRUITING · N/A

A Randomized Multicenter Phase II Trial Evaluating Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab (CB) Versus Best Investigator's Choice (BIC) in Resistance to PD-1/PD-L1 Blockade Due to Antibiotics (ATB) Uptake in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT07001618 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Nsclc Advanced Non Small Cell Lung Cancer?

There are 2 clinical trials listed for Nsclc Advanced Non Small Cell Lung Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Nsclc Advanced Non Small Cell Lung Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Nsclc Advanced Non Small Cell Lung Cancer trials in?

Current Nsclc Advanced Non Small Cell Lung Cancer trials are distributed across: N/A (1), Phase 2 (1).

Find More Trials